<?xml version="1.0" ?>
<document id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a">
  <chunk id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c0" text="Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3">
    <entity charOffset="136-151" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c0.e0" ontology_id="GO_0016310" text="phosphorylation" type="gene_function"/>
  </chunk>
  <chunk id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1" text="Middle East respiratory syndrome coronavirus (MERS-CoV) infection has claimed hundreds of lives and has become a global threat since its emergence in Saudi Arabia in 2012. The ability of MERS-CoV to evade the host innate antiviral response may contribute to its severe pathogenesis. Many MERS-CoV-encoded proteins were identified to have interferon (IFN)-antagonizing properties, which correlates well with the reduced IFN levels observed in infected patients and ex vivo models. In this study, we fully characterized the IFN-antagonizing property of the MERS-CoV M protein. Expression of MERS-CoV M protein suppressed type I IFN expression in response to Sendai virus infection or poly(I:C) induction. This suppressive effect was found to be specific for the activation of IFN regulatory factor 3 (IRF3) but not nuclear factor-ÎºB. MERS-CoV M protein interacted with TRAF3 and disrupted TRAF3-TBK1 association leading to reduced IRF3 activation. M proteins from MERS-CoV and SARS-CoV have three highly similar conserved N-terminal transmembrane domains and a C-terminal region. Using chimeric and truncation mutants, the N-terminal transmembrane domains of the MERS-CoV M protein were found to be sufficient for its inhibitory effect on IFN expression, whereas the C-terminal domain was unable to induce this suppression. Collectively, our findings suggest a common and conserved mechanism through which highly pathogenic MERS-CoV and SARS-CoV harness their M proteins to suppress type I IFN expression at the level of TBK1-dependent phosphorylation and activation of IRF3 resulting in evasion of the host innate antiviral response.">
    <entity charOffset="221-239" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e0" ontology_id="GO_0051607" text="antiviral response" type="gene_function"/>
    <entity charOffset="262-268" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e1" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="1031-1044" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e2" ontology_id="GO_0016021" text="transmembrane" type="gene_function"/>
    <entity charOffset="1132-1145" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e3" ontology_id="GO_0016021" text="transmembrane" type="gene_function"/>
    <entity charOffset="1534-1549" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e4" ontology_id="GO_0016310" text="phosphorylation" type="gene_function"/>
    <entity charOffset="1613-1631" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e5" ontology_id="GO_0051607" text="antiviral response" type="gene_function"/>
    <pair e1="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e0" e2="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e1" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.p0" relation="true"/>
    <pair e1="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e1" e2="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e2" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.p1" relation="true"/>
    <pair e1="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e1" e2="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e3" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.p2" relation="true"/>
    <pair e1="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e1" e2="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e4" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.p3" relation="true"/>
    <pair e1="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e1" e2="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.e5" id="aa973f2833829b97ebdfd6ce2ac6a29b9100db3a.c1.p4" relation="true"/>
  </chunk>
</document>
